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highly localized and limited amount of trophic factor
or signaling molecule (Arancio et al., 1996; Shieh and
Ghosh, 1997). A second possibility is that regulation of
synaptic function is achieved locally at the synapse by
a biochemical tag that specifies those select synapses
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Transcription via the cAMP response element bindingOregon Health Science University
Portland, Oregon 97201 protein (CREB) has been implicated in many forms of
long-term synaptic plasticity (Bourtchuladze et al., 1994;
Bito et al., 1996; Davis et al., 1996; Deisseroth et al.,
1996; Silva et al., 1998). Indeed, CREB has been shownSummary
to participate in signaling via neurotrophins and may be
an essential component of the biochemical tag hypothe-Postsynaptic dCBP (Drosophila homolog of the CREB
binding protein) is required for presynaptic functional sis (Casadio et al., 1999). Here, we demonstrate a role
for the Drosophila homolog of the CREB binding proteindevelopment. Viable, hypomorphic dCBP mutations
have a z50% reduction in presynaptic transmitter re- (dCBP), a transcriptional coactivator of CREB, in the
homeostatic regulation of synaptic functional devel-lease without altering the Ca21 cooperativity of release
or synaptic ultrastructure (total bouton number is in- opment.
CBP was identified as a coactivator of CREB-medi-creased by 25%±30%). Exogenous expression of
dCBP in muscle rescues impaired presynaptic release ated transcription (Chrivia et al., 1993). However, a role
for CBP during synaptic development and plasticity hasin the dCBP mutant background, while presynaptic
dCBP expression does not. In addition, overexpres- not been thoroughly investigated. CBP function is com-
plex and is not restricted to an interaction with CREB.sion experiments indicate that elevated dCBP can also
inhibit presynaptic functional development in a man- CBP can act as a transcriptional coactivator with other
transcriptional partners (Akimaru et al., 1997; Giordanoner distinct from the effects of dCBP loss of function.
Pre- or postsynaptic overexpression of dCBP (in wild and Avantaggiati, 1999; Johnston et al., 1999; Waltzer
and Bienz, 1999). In addition, CBP has been implicatedtype) reduces presynaptic release. However, we do
not observe an increase in bouton number, and pre- as a histone acetylase potentially involved in basal tran-
scriptional regulation (Waltzer and Bienz, 1998, 1999;synaptic overexpression impairs short-term facilita-
tion. These data suggest that dCBP participates in a Giordano and Avantaggiati, 1999). The acetylase activity
of dCBP has also been implicated in the regulation ofpostsynaptic regulatory system that controls func-
tional synaptic development. Wingless signaling through acetylation of Drosophila T
cell factor (Waltzer and Bienz, 1998). Thus, CBP has
numerous functions, acting as a transcriptional regulatorIntroduction
and as an intracellular signaling molecule in the cell
nucleus.The regulation of synaptic growth and plasticity must
Very little is known about the role of CBP at the syn-include mechanisms that constrain synaptic change
apse despite increasing evidence that CREB is an es-within reasonable physiological limits. During develop-
sential element of long-term synaptic plasticity (Davisment, there is a dramatic proliferation and remodeling
et al., 1996; Casadio et al., 1999). Experiments in vitroof new synaptic connections (Buchs and Muller, 1996;
using a GAL4-GFP reporter system indicate that CREB/Katz and Shatz, 1996; Engert and Bonhoeffer, 1999).
CBP-mediated transcription is responsive to differentialIn each system, it is essential that increased synaptic
Ca21 entry through voltage-gated Ca21 channels andfunction is moderate and in register with the normal
ligand-gated ion channels (Hardingham et al., 1999; Huphysiological range of the target neuron (Davis and
et al., 1999). Rubenstein-Taybi syndrome, a disorderGoodman, 1998a, 1998b). A fundamental question con-
characterized by severe mental retardation and limbcerns how a neuron is able to generate a modest, yet
malformation, is associated with a truncation of the CBPphysiologically relevant, change in synaptic function in
gene (Tenaka et al., 1997; Taine et al., 1998). Mice het-response to a developmental or activity-dependent cue.
erozygous for mutations in the CBP locus show domi-One hypothesis for regulated control of synaptic
nant deficits in learning and memory (Tanaka et al., 1997;strengthening is the activity-dependent release of a
Oike et al., 1999). These data implicate CBP as being
essential for normal neural development and activity-§ To whom correspondence should be addressed (e-mail: gdavis@
biochem.ucsf.edu). dependent synaptic plasticity.
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Figure 1. Molecular Characterization of the
dCBP P(EP) Insertions
(A) Schematic diagram of the dCBP genomic
region showing the P(EP) insertion sites up-
stream of the published dCBP sequence. The
published coding sequence (open box) and
position of the 59 end of the published dCBP
sequence (asterisk) are shown. P(EP)1179 and
P(EP)1149 are oriented to overexpress dCBP,
while P(EP)1410 and P(EP)0950 are oppositely ori-
ented. The precise insertion sites for P(EP)
elements 1179, 1410, 0950, and 1149, relative
to the published dCBP sequence, are 2981
base pairs, 2781 base pairs, 2780 base pairs,
and 2747 base pairs upstream of the dCBP
start site, respectively. The approximate po-
sition and orientation of PCR primers used
for PCR amplification are indicated.
(B) P(EP)1179 drives specific overexpression of
the endogenous dCBP transcript in the em-
bryonic nervous system using the elaV-GAL4
driver (ªNeuronal over-expressionº) or in em-
bryonic muscle using the 24B-GAL4 driver
(ªMuscle over-expressionº).
(C) Expression of dCBP in postsynaptic mus-
cle, as detected by anti-dCBP. Expression
in muscle is reduced by z75%±80% in the
hypomorphic loss-of-function mutant back-
ground [P(EP)149] based on reduced fluores-
cence intensity.
Here, we present a complete genetic and electrophys- are in the opposite orientation. P(EP) elements are mo-
bile genetic elements (P elements) containing upstreamiological analysis of dCBP function during synaptic de-
velopment at the Drosophila neuromuscular junction transcription activation sequences (UAS sequence) that
exploit the tendency for P elements to insert in 59 regula-(NMJ). We present evidence that postsynaptic dCBP is
necessary for normal presynaptic functional develop- tory regions of a gene. Insertion of such an element in
the proper 59-39 orientation places random genes underment. In addition, we demonstrate that overexpression
of dCBP can act to inhibit presynaptic functional devel- the control of the UAS element, allowing them to be
expressed in specific tissues under the control of anopment. We propose that dCBP participates in a post-
synaptic homeostatic regulatory system that controls appropriate GAL4 driver.
P(EP)1179 and P(EP)1149 can initiate overexpression ofpresynaptic function through both positive and negative
regulation. This model provides a mechanism that can dCBP. Crossing P(EP)1179 or P(EP)1149 to GAL4 drivers that
promote expression in nerve or muscle causes tissue-allow for the precise control of new synapse formation
during development. specific overexpression of dCBP, as detected by in situ
hybridization using probes specific to the dCBP gene
(Figure 1). Overexpression of dCBP was also demon-Results
strated by RT-PCR using primers from the P(EP) ele-
ments and primers within the dCBP open reading frame.Molecular and Genetic Identification of dCBP P(EP)
Element Mutations Each PCR product isolated by RT-PCR was sequenced
to ensure that the correct open reading frame was drivendCBP is expressed both pre- and postsynaptically at the
developing larval NMJ. dCBP is ubiquitously expressed by the P(EP) element.
To ensure that we are not driving overexpression of anbased on in situ experiments and protein expression
(data not shown). More specifically, an antibody raised additional message located between our P(EP) elements
and the start of the dCBP open reading frame, we sub-against dCBP shows that the protein is present in larval
muscle nuclei (Figure 1) and throughout the CNS (data cloned and sequenced the entire 3 kb genomic region
between P(EP)1179 (the furthest insertion upstream ofnot shown).
We have identified four P(EP) elements that are lo- dCBP) and the start of dCBP. This region did not contain
an additional transcript. Furthermore, our overexpres-cated in a region z3 kb upstream of the dCBP open
reading frame. Two of these elementsÐP(EP)1179 and sion phenotype is phenocopied by overexpression of
the dCBP cDNA under UAS control (see below). BasedP(EP)1149Ðare oriented to overexpress dCBP, and two
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on this sequence data and data obtained from RT-PCR
from the P(EP)1179 and P(EP)1149 elements, we present a
more complete characterization of the 59 untranslated
region of dCBP that extends to, and most likely beyond,
these P(EP) elements. These results also predict that
these P(EP) elements will generate a hypomorphic loss
of dCBP function.
Genetic, histological, and electrophysiological evi-
dence demonstrate that the P(EP) elements P(EP)1149 and
P(EP)1179 are hypomorphic mutations in dCBP. dCBP
expression in muscle nuclei, as detected by an anti-
dCBP antibody, is significantly reduced in the P(EP)1149
hypomorphic mutant (expression being decreased by
z75%±80%, based on reduced fluorescence intensity;
Figure 1). Genetic experiments demonstrate that null
or strong hypomorphic mutations in dCBP die as late
embryos or first instar larvae (Florence and McGinnis,
1998; Waltzer and Bienz, 1998). Patterning defects are
associated with these null mutations (Akimaru et al.,
1997; Florence and McGinnis, 1998; Waltzer and Bienz,
1998). Here, we demonstrate that P(EP)1179 and P(EP)1149
fail to complement previously characterized hypomor-
phic alleles of dCBP, including dCBPTA57 and dCBPS342,
for synaptic transmission defects. P(EP)1179 or P(EP)1149
trans-heterozygous with dCBPTA57 or dCBPS342 are semi-
viable as third instar larvae. These trans-heterozygous
larvae are developmentally delayed by z1 day and
emerge as sluggish third instar larvae. We were therefore
able to proceed with anatomical and electrophysiologi-
cal characterization of these dCBP loss-of-function mu-
tations at the third instar larval synapse.
dCBP Is Necessary for Functional
Synaptic Development
Figure 2. dCBP Loss of Function Decreases Quantal Content with-Hypomorphic dCBP loss-of-function alleles (reduced
out Affecting Quantal Sizefunction) cause a specific z50% decrease in presynap-
(A) Quantification of quantal content, as estimated by dividing thetic transmitter release at the NMJ. The homozygous
average EPSP by the average mEPSP. Average quantal content is
viable P(EP)1149 insertion shows a significant decrease significantly reduced in strong hypomorphic mutations (open bars),
in presynaptic transmitter release (quantal content; see including dCBPQ7/1 (dominant-negative allele), P(EP)1149/P(EP)1149,
Experimental Procedures) without any change in the P(EP)1179/dCBPS342, P(EP)1179/dCBPTA57, and P(EP)1179/dCBPQ7 (p ,
0.01 for all genotypes compared with wild type [closed bar]). Quantalaverage quantal size compared with wild-type and het-
content was not significantly altered in the heterozygous controlserozygous P(EP)1149 element controls (Figure 2). P(EP)1179
(hatched bars), including P(EP)1179/1, P(EP)1149/1, dCBPS342/1, andhomozygous viable larvae do not show any change in
dCBPTA57/1. Quantal size is not significantly altered in any genotype
synaptic structure or function. However, when P(EP)1179 compared with wild type. The number of recordings for each geno-
is placed in trans to known hypomorphic alleles of dCBP, type is shown above the bar. Representative EPSPs from wild type
including dCBPTA57 and dCBPS342, we observe a decrease and a strong hypomorphic mutation are shown above the graphs.
Coding of genotypes in this and subsequent figures are is follows:in presynaptic quantal content that is identical to that
wild type, closed bars; heterozygous controls, hatched bars; andobserved in P(EP)1149 homozygous larvae; there is a
experimental genotypes, open bars.z50% decrease in quantal content without any change
(B) Distribution of mEPSPs for recordings of wild type and P(EP)1179/
in quantal size compared with wild-type and heterozy- dCBPTA57 (abbreviations: n, number of events; q, mean quantal size).
gous controls, including P(EP)1179/1, dCBPS342/1, and Inset, sample traces for each genotype. The distribution of mEPSPs
dCBPTA57/1 (Figure 2). We never observed a change in is unaltered in strong dCBP hypomorphs.
the average muscle resting potential or in the average
muscle input resistance in any genotype demonstrating
the specificity of these phenotypes to changes in pre- dCBPQ7 shows a dominant reduction in presynaptic
transmitter release without any change in quantal sizesynaptic release.
Previously identified homozygous dCBP mutations (Figure 2). The anatomical and electrophysiological phe-
notypes of the dCBPQ7 allele are identical to the pheno-are all lethal during early development. We therefore
used a previously identified dominant-negative allele of types of the P(EP)1149 homozygous larvae and to P(EP)1179
in trans with dCBPTA57 and dCBPS342. Consistent withdCBP to further demonstrate the specificity of this dCBP
physiological phenotype. The dCBPQ7 allele has been dCBPQ7 having a dominant-negative (antimorphic) activ-
ity, the electophysiological phenotype is not significantlycharacterized as an antimorphic allele with a presumed
dominant-negative function (Florence and McGinnis, enhanced in trans to the P(EP)1179 loss-of-function inser-
tion (Figure 2). Thus, our recently identified hypomorphic1988). Consistent with these previously published data,
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Figure 4. Presynaptic dCBP Overexpression Decreases Quantal
Content without Affecting Quantal SizeFigure 3. Postsynaptic dCBP Expression Rescues Presynaptic
Transmitter Release in the dCBP Mutant Background (A) Quantification of quantal content, as estimated by dividing the
average EPSP by the average mEPSP. Average quantal content isQuantal content and quantal size are quantified for dCBP loss of
significantly reduced in genotypes that overexpress dCBP presyn-function (ªLoss of Functionº) and when dCBP is expressed in post-
aptically, including P(EP)1149/1;elaV3A4/1, P(EP)1179/1;elaV 3A4/1,synaptic muscle in this loss-of-function genetic background (ªMus-
and UAS-dCBP/1;elaV 3A4/1. Quantal size is not significantly alteredcle Rescue in LOF Backgroundº). Sample traces are shown at the
in any genotype compared with wild type. The number of recordingstop for each genetic background (traces are signal averages of
for each genotype is shown above the bar. Representative EPSPs10±20 individual EPSPs). dCBP expression is shown schematically
from wild type and presynaptic overexpressing genotypes areabove each bar of the graph.
shown above the graphs.
(B) Distribution of mEPSPs for recordings of wild type and
P(EP)1179/elaV3A4dCBPTA57 (abbreviations: n, number of events; q,
P(EP) element insertions in the 59 UTR of dCBP show mean quantal size). Inset, sample traces for each genotype. Presyn-
an electrophysiological phenotype that is identical to a aptic overexpression of dCBP does not alter the distribution of
dCBP dominant-negative allele and fail to complement mEPSPs compared with wild type.
previously identified hypomorphic alleles of dCBP, indi-
cating that these P(EP) elements disrupt dCBP activity. either MHC-GAL4 (all muscle) or elaV-GAL4 (all neu-
These data demonstrate that dCBP is necessary for rons). Expression of dCBP in muscle in the hypomorphic
functional synaptic development at the NMJ. mutant background rescues presynaptic quantal con-
tent to wild-type levels (Figure 3). However, expression
of dCBP in nerve in the same hypomorphic mutant back-Postsynaptic dCBP Rescues Presynaptic Release
in the Loss-of-Function Mutant ground resulted in early larval lethality (0.5% survival).
Thus, postsynaptic dCBP can rescue presynaptic func-To address whether dCBP is necessary in the pre-
or postsynaptic cell for normal synaptic development, tional development in the hypomorphic mutant back-
ground.we have rescued dCBP expression on either side of
the synapse in the hypomorphic mutant background.
P(EP)1149 males show a z50% reduction in presynaptic dCBP Overexpression Inhibits Functional
Presynaptic Developmenttransmitter release that is identical to homozygous fe-
males and other loss-of-function allelic combinations Overexpression of dCBP in either the pre- or postsynap-
tic cell causes a reduction in presynaptic transmitter(Figure 3). We therefore used P(EP)1149 males as a hypo-
morphic mutant background and expressed dCBP with release (Figures 4 and 5). dCBP was overexpressed in
dCBP Function during Synaptic Development
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using elaV-GAL4, we observe a reduction in presynaptic
release identical to the overexpression of UAS-dCBP.
Overexpression of dCBP in muscle, or in both muscle
and nerve, also inhibits presynaptic transmitter release
(Figure 5). Again, we do not observe any change in
quantal size or muscle physiological parameters. We
conclude that overexpression of dCBP either pre- or
postsynaptically inhibits presynaptic functional devel-
opment.
Ultrastructural Analysis
We examined the synaptic ultrastructure to determine
whether the observed impairment of presynaptic release
is due to gross ultrastructural abnormalities. Synaptic
ultrastructure appears normal at neuromuscular bou-
tons in both gain- and loss-of-function genetic back-
grounds despite reduced presynaptic transmitter re-
lease at these synapses. There does not appear to be
any alteration in the extent of subsynaptic reticulum
or in the integrity of individual active zones (Figure 6).
Indeed, there is an increase in the number of presynaptic
T bars per active zone in the dCBP loss-of-function
synapse (n 5 183 active zones in P(EP)1149, and n 5
219 active zones in wild type, p , 0.001). It has been
hypothesized that T bars may facilitate transmitter re-
lease; however, their precise function in synaptic trans-
mission remains unclear. We therefore conclude that
gross ultrastructural abnormalities are not the cause of
decreased presynaptic release.
Synapse Morphology at dCBP Gain- and
Loss-of-Function Mutant Synapses
A morphological analysis demonstrates that reduced
transmitter release in the dCBP gain- and loss-of-func-
tion backgrounds is not due to a disruption of morpho-
Figure 5. Postsynaptic dCBP Overexpression Decreases Quantal logical synaptic development. Synaptic structure and
Content without Affecting Quantal Size function were both calculated for each individual prepa-
(A) Quantal content and quantal size are quantified for two genetic ration by fixing and staining each electrophysiological
controls and when dCBP is overexpressed in muscle using MHC- preparation with anti-Synaptotagmin to reveal the nerve
GAL4 and UAS-dCBP. A significant difference is observed for terminal boutons. Thus, we can precisely correlate
quantal content at the UAS-dCBP/MHC-GAL482 synapse (expres-
changes in synaptic function with a change in the syn-sion postsynaptically) and at the P(EP)1179/1;elaV-GAL4/1;MHC-
apse morphology. Strong loss-of-function allelic combi-GAL482/1 synapse (expression both pre- and postsynaptically) com-
nations and the dominant-negative dCBPQ7 allele allpared with all other genotypes (p , 0.001, student's t test). Sample
traces are shown at top (averages of 10±20 individual EPSPs). cause an increase in bouton number (255; 35% increase)
(B) There is no change in the distribution of spontaneous miniature at the NMJ of muscles 6 and 7 (Figure 7) and muscle 4
release events when dCBP is overexpressed in muscle. The number (data not shown). There is only a modest change in the
of events analyzed (n), the average quantal size (q), and the standard
number of synaptic boutons, and, therefore, we suspectdeviation (6) are indicated for each histogram. Inset, sample traces
that this is a compensatory response due to the ob-showing spontaneous miniature release events from the distribution
served decrease in synaptic function in these dCBPquantified in each histogram.
mutants. These data indicate that the health of the pre-
and postsynaptic cells has not been compromised.
In contrast, overexpression of dCBP either pre- orthe wild-type background using the dCBP cDNA under
UAS control (UAS-dCBP). Presynaptic overexpression postsynaptically does not alter bouton number despite
a reduction in transmitter release that is comparable towas driven by elaV-GAL4. We observe a decrease in
presynaptic transmitter release (z70%) without a that observed at dCBP loss-of-function synapses (Fig-
ure 7). Thus, dCBP overexpression inhibits presynapticchange in the average size or distribution of the sponta-
neous miniature release events and without any change release without any morphological compensation.
We have also performed experiments to control forin the average resting potential or average input resis-
tance of the postsynaptic muscle (Figure 4). We also over- any potential dCBP-dependant alteration in axon guid-
ance, target selection, or alteration in neuronal and glialexpressed dCBP from either P(EP)1149/1 or P(EP)1179/1.
These heterozygous P(EP) elements are electrophysi- cell fate at dCBP gain- or loss-of-function backgrounds.
Synaptic connectivity in the larval neuromuscular sys-ologically wild type in the absence of GAL4 (Figure 4).
When dCBP is overexpressed from the P(EP) elements tem appears normal based on visual inspection of type
Neuron
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Figure 6. Synaptic Ultrastructure Is Normal
in dCBP Mutants and When dCBP Is Overex-
pressed
Single sections from EM serial reconstruction
of third instar synapses on muscle 6 in ab-
dominal segment 3.
(A) Cross-section of a wild-type bouton. Ac-
tive zones with T bars are indicated (asterisk).
(B) Cross-section of a synaptic bouton from
dCBP loss of function, P(EP)1149/P(EP)1149. In-
set, higher magnification of an active zone
with a presynaptic T bar.
(C) Cross-section of a synaptic bouton from
a synapse overexpressing dCBP both pre-
and postsynaptically [P(EP)1179;elaV-GAL4;
MHC-GAL4].
Ia, type Ib, and type II synapses at muscle 6, 7, 13, 12, glial cell bodies in the embryo and larva, visualized with
the anti-REPO antibody. We did not observe any change4, 3, 2, and 1. These synapses were inspected during
the quantitation of bouton number in each genotype in the number or distribution of glia within the embryonic
or larval CNS or PNS (data not shown).(over 400 segments analyzed). We do not observe any
alteration in axon guidance in the embryonic CNS, indi-
cating that cell fate and guidance are normal in the CNS Ca21 Cooperativity and Synaptic Facilitation
We performed additional experiments to determine(data not shown). In the embryo, we do observe weakly
penetrant axon guidance defects in the neuromuscular whether decreased transmitter release in the dCBP
gain-of-function and dCBP loss-of-function mutationssystem (data not shown). In the experiments presented
here, we controlled for any defect in target selection by can be further distinguished. We examined the Ca21
dependence of transmitter release at synapses with ei-quantitating synapse morphology and bouton number
for each electrophysiological preparation. We did not ther increased or decreased dCBP. At both dCBP gain-
and loss-of-function synapses, the Ca21 cooperativityobserve any alteration in target selection or innervation
at the muscles from which we recorded electrophysio- of transmitter release remains in the range of what is
considered to be wild type (slope, z4) despite a shiftlogically. Finally, we have examined the distribution of
dCBP Function during Synaptic Development
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Figure 8. Ca21 Cooperativity and Facilitation in dCBP Gain and Loss
of Function
(A) Ca21 cooperativity data are shown for both dCBP loss of func-
tion [P(EP)1149/P(EP)1149 (R2 5 0.9894) and P(EP)1149/dCBPS342 (R2 5
0.9626)] and presynaptic overexpression [UAS-dCBP/1;elaV 3A4/1
(R2 5 0.9925)] compared with wild type (R2 5 0.9951). Cooperativity
is maintained within a normal range (slope, z4) despite a consistent
reduction in cooperativity in the two loss-of-function genetic back-
grounds.
(B) Short-term facilitation is examined at wild-type synapses (closed
bars) at two different Ca21 concentrations (0.5 mM and 0.35 mM).
Figure 7. Hypomorphic Mutations in dCBP Cause a Moderate In-
Facilitation is also examined at 0.5 mM Ca21 in both dCBP loss
crease in Synapse Size
of function [P(EP)1149/P(EP)1149] and when dCBP is overexpressed
(A) Representative light micrographs of muscles 6 and 7 in segment presynaptically in the wild-type genetic background [UAS-dCBP/1;
A3 of wild type and dCBP loss-of-function (P(EP)1179/dCBPTA57 ) third elaV-GAL4/1].
instar larvae stained with anti-Fasciclin II and anti-Synaptotagmin.
dCBP loss of function causes a moderate (z25%) increase in bouton
and loss-of-function backgrounds is not due to a sub-number.
stantial alteration in the Ca21-dependent transmitter re-(B and C) Quantification of synapse size in dCBP loss-of-function
(B) and overexpression (C) genotypes. Synapse size was quantified lease mechanism (Figure 8).
by staining with anti-Fasciclin II and anti-Synaptotagmin and count- We also analyzed short-term facilitation in these dCBP
ing boutons at muscles 6 and 7 of segment A3 in third instar larvae. gain- and loss-of-function backgrounds. Short-term fa-
Strong dCBP loss-of-function mutations show a significant increase cilitation was induced with five stimuli delivered with an
in synapse size, including P(EP)1179/dCBPS342, P(EP)1149/dCBPS342,
interpulse interval of 50 ms (20 Hz). Facilitation wasP(EP)1179/dCBPTA57, P(EP)1149/dCBPTA57, dCBPQ7/1 (dominant-nega-
calculated by the percent change in excitatory postsyn-tive), P(EP)1179/dCBPQ7, and P(EP)1149/dCBPQ7 (p , 0.01). One presyn-
aptic potential (EPSP) amplitude from the first to theaptic overexpression genotype (P(EP)1179/1;elaV 3A4/1) showed a sig-
nificant decrease in synapse size (p 5 0.013). fifth EPSP (Davis et al., 1996). In the dCBP mutant back-
ground, there is 74% facilitation compared with 9% facil-
itation in wild type at 0.5 mM extracellular Ca21. How-
toward smaller quantal contents at all but the lowest ever, the initial EPSP in the dCBP mutant background
Ca21 concentrations used (Figure 8). There is a consis- is 50% of that of wild type. When we reduced the first
tent reduction in the cooperativity of release in the loss- EPSP in wild-type larvae to a similar level (10.0 6 1.2 mV)
of-function background compared with wild-type and by recording in 0.35 mM extracellular Ca21, we observed
dCBP overexpression. However, this change in cooper- 73% facilitation. These data indicate that altered facilita-
ativity is relatively minor. These data demonstrate that tion in the dCBP mutant background is due to a reduc-
tion in the initial EPSP amplitude. These data furtherthe decrease in presynaptic release in the dCBP gain-
Neuron
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normal presynaptic transmitter release at the NMJ. This
indicates that dCBP participates in a retrograde signal-
ing pathway that controls presynaptic development. We
further demonstrate that dCBP can inhibit the develop-
ment of presynaptic transmitter release when overex-
pressed either pre- or postsynaptically. This indicates
that dCBP-dependent mechanisms can act as both pos-
itive and negative regulators of presynaptic develop-
ment. We hypothesize that postsynaptic dCBP partici-
pates in the homeostatic control of presynaptic function.
dCBP Is Necessary for Presynaptic
Functional Development
We have analyzed five different loss-of-function alleles
of dCBP. In each viable genetic combination in which
dCBP activity is reduced, there is a 45%±50% decrease
in presynaptic transmitter release. The observed de-
crease in presynaptic release is severe, being compara-
ble to phenotypes observed in Synaptotagmin mutant
larvae (Littleton et al., 1993; DiAntonio and Schwarz,
1994). The loss of dCBP does not alter the health of the
synapse, as assayed by light microscopy and ultrastruc-
tural analysis, and is not due to altered muscle innerva-
tion or altered glial or neuronal cell fate. Thus, dCBP
loss of function dramatically and specifically impairs
functional synaptic development.
Genetic rescue experiments indicate that the develop-
mental requirement for dCBP is postsynaptic. Exoge-
Figure 9. dCBP Both Positively and Negatively Regulates Presyn-
nous expression of dCBP in muscle in the loss-of-func-aptic Functional Development
tion genetic background rescues presynaptic functional
(A) Summary of results from loss-of-function and rescue experi-
development to wild type. Since transmitter release isments.
wild type despite reduced presynaptic dCBP, we con-(B) Summary of experiments overexpressing dCBP either pre- or
postsynaptically in the wild-type genetic background. A reference clude that postsynaptic dCBP expression is necessary
to primary data is indicated below each experiment. Levels of dCBP for normal functional synaptic development. These
expression are indicated schematically, with darker shading indicat- postsynaptic rescue data also suggest that postsynap-
ing higher levels of expression. tic dCBP may be sufficient for presynaptic functional
development. However, these rescues are conducted
in hypomorphic loss-of-function backgrounds, and, as
suggest that reduced transmitter release in the dCBP such, there remains a residual level of dCBP presynapti-
loss-of-function background may be due to a reduction cally (Figures 2, 3, and 9).
in the probability of presynaptic release. Expression of dCBP presynaptically in the loss-of-
Facilitation at synapses with presynaptic dCBP over- function background causes lethality. We hypothesize
expression is not increased despite a z50% reduction that this lethality is due to an additive effect of dCBP
in the initial EPSP amplitude. At 0.5 mM extracellular loss of function postsynaptically and an inhibitory effect
Ca21, we observe 23% facilitation. This is significantly of presynaptic dCBP overexpression. Overexpression
less facilitation than observed at dCBP loss-of-function presynaptically in the wild-type background (normal
synapses and at wild-type synapses in 0.35 mM Ca21, muscle dCBP) inhibits transmitter release. Additional
which have a comparable initial EPSP amplitude. Thus, data indicate that the inhibitory effect of dCBP overex-
the reduced initial EPSP amplitude in dCBP neuronal pression may act via a mechanism different from dCBP
gain of function does not correlate with increased facili- loss of function (see next section). Therefore, the effects
tation, suggesting that decreased transmitter release of presynaptic overexpression and postsynaptic loss of
may be due to a reduction in the number of functional function are likely to be additive. However, these data
active zones. However, we do not observe a change also raise the possibility that the ratio of dCBP expres-
in the frequency of spontaneous vesicle fusion events sion in the presynaptic neuron, relative to the postsynap-
(mEPSPs) in dCBP neuronal gain of function compared tic target, may also be an important parameter. We are
with wild type (data not shown). In conclusion, reduced unable to assay expression levels accurately enough to
transmitter release in dCBP gain- and loss-of-function address this issue.
is likely due to different mechanisms.
Discussion dCBP Overexpression Inhibits Presynaptic Functional
Synaptic Development
Overexpression of dCBP in the postsynaptic muscle orOur data demonstrate that postsynaptic dCBP is neces-
sary and may also be sufficient for the development of the presynaptic nerve inhibits presynaptic transmitter
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release (Figures 4, 5, and 9b). Anatomical, ultrastruc- in the homeostatic regulation of presynaptic transmitter
release (G. W. Davis et al., submitted). We demonstratetural, and electrophysiological data indicate that dCBP
here that perturbations in postsynaptic dCBP can affectoverexpression does not poison the synapse. One pos-
presynaptic transmitter release. Furthermore, postsyn-sibility is that overexpression of wild-type dCBP in the
aptic dCBP can act as both a positive and negativewild-type genetic background can somehow act as a
regulator of synaptic function. Finally, CBP in Drosophiladominant-negative and therefore mimics the loss-of-
and other systems is well suited to participate in a sys-function phenotype. However, postsynaptic dCBP ex-
tem that monitors postsynaptic activity. CBP functionpression can rescue the loss-of-function phenotype, in-
can be regulated by Ca21 influx through voltage-gateddicating that exogenous dCBP can function correctly
channels and ionotropic receptors (Hardingham et al.,during synaptic development. In addition, the gain- and
1999; Hu et al., 1999). Furthermore, CBP can act as aloss-of-function phenotypes can be distinguished by
transcriptional coactivator with CREB and other tran-differential changes in synapse morphology and short-
scription factors, as well as function as an intracellularterm facilitation. Therefore, we interpret our overexpres-
signaling molecule via acetylase activity (Waltzer andsion data as indicating that dCBP can function normally
Bienz, 1998). In conclusion, we propose that dCBP is anto inhibit presynaptic functional development by a
essential component of the postsynaptic homeostaticmechanism that is distinct from dCBP loss of function.
mechanism that monitors activity and regulates presyn-We observe increased synapse morphology in the
aptic transmitter release.loss-of-function background, while there is no change
We have previously proposed that the homeostaticin bouton number when dCBP is overexpressed either
retrograde increase in presynaptic release is due to apre- or postsynaptically. Since the increased morphol-
signal that can enhance presynaptic transmission, simi-ogy in the dCBP mutant background is moderate, we
lar to that proposed for the presynaptic expression ofhypothesize that this is a compensatory response due
long-term potentiation (Bliss and Collingridge, 1993).to reduced presynaptic release. This implies that dCBP
Our current data suggest an additional model, that aoverexpression blocks this form of compensation. How-
homeostatic increase in presynaptic transmission couldever, it is unclear whether this is a direct or indirect
also be achieved by relieving an inhibitory signal derivedeffect of dCBP overexpression.
from postsynaptic dCBP function.dCBP gain- and loss-of-function phenotypes can also
Homeostatic control of presynaptic function at thebe distinguished by analysis of short-term facilitation.
Drosophila NMJ ensures that presynaptic release is pre-There is a reduction in the initial EPSP amplitude in both
cisely coupled to the growth of the postsynaptic muscledCBP gain and loss of function. At 0.5 mM extracellular
throughout development. To achieve constant muscleCa21, the reduced initial EPSP is correlated with in-
depolarization during development, homeostatic signal-creased facilitation at the dCBP loss-of-function syn-
ing must achieve a progressive and gradual increase inapse, whereas facilitation is normal in the dCBP gain-
synaptic function. A progressive and gradual increaseof-function synapse (despite a reduced initial EPSP).
in synaptic function could be achieved through dCBP-When the initial EPSP amplitude at a wild-type synapse
dependent mechanisms since it can both promote andis experimentally reduced by reducing extracellular Ca21
inhibit synaptic development. Activation of dCBP could(to 0.35 mM Ca21), we observe facilitation that is similar
promote synaptic strengthening, while sustained dCBPto that observed at a dCBP loss-of-function synapse
activation could inhibit further synaptic development,recorded at 0.5 mM Ca21. These data indicate that the
preventing runaway excitation. This is consistent withEPSP amplitude is reduced by different mechanisms in
our demonstration that postsynaptic dCBP is necessarythe dCBP gain- and loss-of-function genetic back-
for normal synaptic development but that sustainedgrounds. We suspect that dCBP overexpression inhibits
overexpression of dCBP can inhibit presynaptic func-
some aspect of presynaptic release that is independent
tional development.
of the probability of presynaptic release.
CBP/CREB Function during Synaptic Development
dCBP and the Homeostatic Regulation and Activity-Dependent Plasticity
of Synaptic Function Our results are consistent with previous data examining
At the larval NMJ, an experimental decrease in postsyn- CREB activity in Drosophila. Neither CREB nor dCBP
aptic excitation causes a compensatory enhancement directly alters synaptic morphology (Davis et al., 1996).
of presynaptic release (Petersen et al., 1997; Davis et al., Here, we demonstrate a role for dCBP in regulated func-
1998). These previous experiments define a homeostatic tional synaptic development. However, we have pre-
regulatory system that maintains postsynaptic excita- viously demonstrated that CREB is unlikely to be in-
tion through a retrograde signal(s) from muscle to nerve. volved in synaptic development based on heat shock
A homeostatic regulatory system will likely include overexpression of dCREB2b (Davis et al., 1996). Thus,
mechanisms that can monitor postsynaptic excitation dCBP may regulate synaptic development though non
and transduce this information through a retrograde sig- CREB-dependent mechanisms.
nal to modulate presynaptic transmitter release. In prin- In vertebrates, CBP has been broadly implicated as
ciple, homeostatic regulation will require both positive being necessary for normal brain development, as well
and negative regulation of synaptic function. as learning. CBP mutant mice show dominant defects
We hypothesize that dCBP is centrally involved in in neuronal development, as well as learning and mem-
the mechanisms that monitor postsynaptic activity. We ory. In humans, CBP mutations are associated with Ru-
identified the dCBP P(EP) element mutations described benstein-Taybi syndrome, a disorder that is character-
ized by developmental limb defects and severe mentalhere in a screen for mutations in genes that participate
Neuron
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dCBP antibody (chicken). dCBP imaging was done on a DeltaVisionretardation (Tenaka et al., 1997). Our data implicate
deconvolution confocal microscope (Applied Precision). RelativedCBP as having a specific role at the synapse. A similar
fluorescence intensity was measured using the line profile tool ofrole for CBP in vertebrate systems could contribute to
DeltaVision software, allowing comparison of pixel intensity be-
our understanding of the observed phenotypes. tween the muscle and nuclear dCBP fluorescence. Averages were
CBP is a transcriptional coactivator for CREB. CREB take from 30±40 muscle nuclei from 24±30 separate synapses in
wild-type and P(EP)1149 homozygous mutant larvae.has been investigated in detail for a role in activity-
dependent synaptic plasticity (Bartsch et al., 1995, 1998;
Molecular ReagentsDeisseroth et al., 1996; Yin and Tully, 1996; Casadio et
Genomic sequences flanking the P element insertion were amplifiedal., 1999). CREB has also been implicated in the mecha-
by PCR from P(EP)1179 genomic DNA using a primer from the 39 endnisms of learning in the mouse (Silva et al., 1998). In
of the P element (pry2) and primers from dCBP (nej1, nej2, and nej4).
Aplysia, presynaptic CREB is considered necessary for PCR products were cloned into pGEM-T (Promega) and sequenced.
seratonin- and protein synthesis±dependent long-term For analysis of the P element±driven transcript, P(EP)1179 females
were crossed to heat shock GAL4 males. Embryos were heatsynaptic facilitation (Bartch et al., 1995, 1998; Casadio
shocked at 378C for 2 hr, and the RNA isolated (Qiagen). RT-PCRet al., 1999). Experiments on vertebrate neurons in cell
was performed (GIBCO) using the following primer pairs: first round,culture implicate a role for postsynaptic CREB in activ-
pr192 and nej2; second round, pr200 and nej1. In situ hybridizationsity-dependent plasticity and neurotrophin-dependent
were performed on embryos derived from two GAL4 enhancer lines,
neuronal survival (Deisseroth et al., 1996; Finkbeiner et 24B-GAL4 and elaV-GAL43A4, crossed to P(EP)1179 females. Embryos
al., 1997). CBP has also been implicated in the neuro- were probed with a dCBP probe. The dCBP probe was generated
from bases 766 to 1279 of the known dCBP sequence and subclonedtrophin-dependent survival mechanisms (Liu et al.,
into pGEM-T, and the digoxigenin-labeled RNA probe was synthe-1998). However, the precise relationship between CREB
sized accordingly (Roche Molecular Biochemicals). The sequencesand CBP in the control of these processes remains un-
for the PCR primers designated in Figure 1 are as follows: pry2,clear. For example, CREB and CBP may be differentially
CTTGCCGACGGGACCACCTTATGTTATT; pr192, GAGTTAATTCAA
phosphorylated in response to different sources of post- ACCCCACGGACATGC; pr200, CTCTAGACAAGCATACGTTAAGTG
synaptic Ca21 influx (Hardingham et al., 1999; Hu et al., GATGTC; nej1, CGAGGACACCAGCTCATC; nej2, GGATTCCCGCT
TACCAG; and nej4, GTGGTGCTGGAATGTTGC.1999). In addition, CBP is known to act as a coactivator
with other transcription factors and as a signaling mole-
Electrophysiologycule via acetylase activity (Johnston et al., 1999; Waltzer
All recordings were made from muscle fiber 6 in abdominal segmentand Bienz 1998, 1999). Drosophila now opens the possi-
A3 in 0.5 mM Ca21 HL3 saline, as previously described, except
bility for a forward genetic analysis of CBP function at where indicated (Davis et al., 1996). For each recording, the resting
the synapse. membrane potential and input resistance were recorded. Only re-
cordings with resting potentials of at least 260 and input resistances
of at least 8 MV were included in our analysis. Quantal content wasExperimental Procedures
calculated by dividing the average maximal EPSP amplitude by
the average amplitude of the spontaneous miniature release eventsElectron Microscopy
(mEPSP). Quantal size was determined by the average amplitudeWild-type and mutant larvae were prepared for electron microscropy
of the spontaneous release events recorded in the absence of stimu-(EM) according to procedures previously described (Schuster et al.,
lation. To compare the distribution of spontaneous release events1996). Serial sections were taken at 0.1 mm, as described previously.
between different mutant lines, mEPSPs were pooled for at leastEM for dCBP loss-of-function analysis was done on homozygous
five recordings from at least five preparations in which the muscleP(EP)1149 third instar larvae.
input resistance and resting membrane potentials were closely
matched (RMP, between 265 and 272; Rin, between 8 and 9 MV).Genetics
Frequency-dependent facilitation experiments were performed andP(EP)1149 and P(EP)1179 were obtained from the Berkeley Drosophila
quantified as described previously (Davis et al., 1996). Measure-Genome Project. dCBPS342/Fm7c, dCBPTA57/Fm7c, and dCBPQ7/
ments of maximal EPSP amplitude were done by hand, as describedFM7c were obtained from the laboratory of William McGinnis. Homo-
previously. Measurements of spontaneous miniature release eventszygous lethal dCBP alleles were maintained over an Fm7c-kruppel-
were semiautomated using MiniAnalysis software (Jaejin) and editedGFP balancer (provided by Tom Kornberg). dCBP mutant chromo-
by hand.somes were identified in the larvae based on malpigian tubule and
mouth hook color (Schuster et al., 1996) and based on the absence
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